Displaying items by tag: daclatasvir

On the 20th May 2015 the Medicines and Healthcare products Regulatory Agency in the UK issued a Drug Safety Update titled:

Sofosbuvir with daclatasvir; sofosbuvir and ledipasvir: risks of severe bradycardia and heart block when taken with amiodarone.

You will find a link to it at:

https://www.gov.uk/drug-safety-update/sofosbuvir-with-daclatasvir-sofosbuvir-and-ledipasvir-risks-of-severe-bradycardia-and-heart-block-when-taken-with-amiodarone

GENEVA - WHO today published the new edition of its Model List of Essential Medicines which includes ground-breaking new treatments for hepatitis C.

http://www.who.int/mediacentre/news/releases/2015/new-essential-medicines-list/en/